NANO LABS LTD-CL A (NA) Stock Balance Sheet
USA - NASDAQ:NA - KYG6391Y1281 - Common Stock
4.21 USD
-0.33 (-7.27%)
4.21 USD
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | null | 48.16M | 87.81M | 233.85M | 35.33M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | 0 | 31.89M | 0 | |||
| Receivables | 51.00M | 35.78M | 23.73M | 33.08M | 7.34M | |||
| Inventories | 30.00M | 12.88M | 102.20M | 213.87M | 7.24M | |||
| Other Current Assets | 252.61M | 28.67M | 74.91M | 380.74M | 9.10M | |||
| Total Current Assets | 367.00M | 125.49M | 288.65M | 893.43M | 59.01M | |||
| Non-Current Assets | ||||||||
| PPE Net | 203.00M | 177.08M | 29.88M | 16.41M | 1.83M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 47.00M | 47.73M | 48.72M | 0 | 99.00K | |||
| Other Non-Current Assets | null | null | null | 0 | 550.00K | |||
| Total Non-Current Assets | 249.00M | 224.81M | 78.59M | 16.41M | 2.48M | |||
| TOTAL ASSETS | 616.00M | 350.30M | 367.24M | 909.83M | 61.49M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 18.00M | 20.00M | 0 | 0 | 5.00M | |||
| Current Portion Of LT Debt. | 5.35M | 3.41M | 280.00K | null | null | |||
| Accrued Expenses | 5.92M | 10.49M | 4.20M | 5.22M | 462.00K | |||
| Accounts Payable | 18.00M | 16.88M | 15.29M | 2.84M | 36.97M | |||
| Other Current Liabilities | 162.00M | 191.79M | 163.87M | 924.31M | 67.30M | |||
| Total Current Liabilities | 209.00M | 242.57M | 183.64M | 932.37M | 109.74M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 171.00M | 120.26M | 16.67M | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 2.92M | 3.73M | 2.51M | 2.12M | 277.00K | |||
| Total Non-Current Liabilities | 176.00M | 122.46M | 19.19M | 2.12M | 277.00K | |||
| TOTAL LIABILITIES | 385.00M | 365.03M | 202.83M | 934.49M | 110.01M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -559.00M | -445.38M | -192.56M | -223.68M | -48.73M | |||
| Additional Paid In Capital | 780.00M | 428.31M | 354.80M | 201.42M | 164.00K | |||
| Minority Interest | 2.12M | -1.53M | null | null | null | |||
| Common Shares | 210.00K | 87.00K | 72.00K | 67.00K | 51.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 8.65M | 2.25M | 2.10M | -2.47M | 0 | |||
| Shares Outstanding | 61.48M | 252.97M | 428.46M | 412.44M | 412.44M | |||
| Tangible Book Value per Share | 11.5 | -0.9489 | 1.0377 | -0.2298 | -0.453 | |||
| Total Shareholders' Equity | 231.00M | -14.73M | 164.41M | -24.66M | -48.52M | |||
| TOTAL LIABILITIES AND EQUITY | 616.00M | 350.30M | 367.24M | 909.83M | 61.49M | |||
| Statistics | ||||||||
| Debt/Equity | 0.82 | -9.52 | 0.10 | N/A | N/A | |||
| Current Ratio | 1.76 | 0.52 | 1.57 | 0.96 | 0.54 | |||
| Return On Assets (ROA) | -18.34% | -72.17% | 8.47% | -19.23% | -61.31% | |||
| Return On Equity (ROE) | -48.92% | N/A | 18.93% | N/A | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 8.90% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 17.06% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | 34.71% | N/A | N/A | |||
All data in CNY , ROIC based on taxRate of 0.21